Global Antibody Drugs Market Professional Survey Report 2016

1 Industry Overview of Antibody Drugs

1.1 Definition and Specifications of Antibody Drugs

1.1.1 Definition of Antibody Drugs

1.1.2 Specifications of Antibody Drugs

1.2 Classification of Antibody Drugs

1.2.1 Fully human antibodies

1.2.2 Humanized antibody

1.2.3 Murine

1.2.4 Chimeric antibodies

1.3 Applications of Antibody Drugs

1.3.1 Cancer Treatment

1.3.2 Autoimmune diseases

1.3.3 Organ Transplantation

1.3.4 Others

1.4 Industry Chain Structure of Antibody Drugs

1.5 Industry Overview and Major Regions Status of Antibody Drugs

1.5.1 Industry Overview of Antibody Drugs

1.5.2 Global Major Regions Status of Antibody Drugs

1.6 Industry Policy Analysis of Antibody Drugs

1.7 Industry News Analysis of Antibody Drugs

2 Manufacturing Cost Structure Analysis of Antibody Drugs

2.1 Raw Material Suppliers and Price Analysis of Antibody Drugs

2.2 Equipment Suppliers and Price Analysis of Antibody Drugs

2.3 Labor Cost Analysis of Antibody Drugs

2.4 Other Costs Analysis of Antibody Drugs

2.5 Manufacturing Cost Structure Analysis of Antibody Drugs

2.6 Manufacturing Process Analysis of Antibody Drugs

3 Technical Data and Manufacturing Plants Analysis of Antibody Drugs

3.1 Capacity and Commercial Production Date of Global Antibody Drugs Major Manufacturers in 2015

3.2 Manufacturing Plants Distribution of Global Antibody Drugs Major Manufacturers in 2015

3.3 R&D Status and Technology Source of Global Antibody Drugs Major Manufacturers in 2015

3.4 Raw Materials Sources Analysis of Global Antibody Drugs Major Manufacturers in 2015

4 Global Antibody Drugs Overall Market Overview

4.1 2011-2016E Overall Market Analysis

4.2.1 2011-2015 Global Antibody Drugs Capacity and Growth Rate Analysis

4.2.2 2015 Antibody Drugs Capacity Analysis (Company Segment)

4.3 Sales Analysis

4.3.1 2011-2015 Global Antibody Drugs Sales and Growth Rate Analysis

4.3.2 2015 Antibody Drugs Sales Analysis (Company Segment)

4.4 Sales Price Analysis

4.4.1 2011-2015 Global Antibody Drugs Sales Price

4.4.2 2015 Antibody Drugs Sales Price Analysis (Company Segment)

4.5 Gross Margin Analysis

4.5.1 2011-2015 Global Antibody Drugs Gross Margin

4.5.2 2015 Antibody Drugs Gross Margin Analysis (Company Segment)

5 Antibody Drugs Regional Market Analysis

5.1 North America Antibody Drugs Market Analysis

5.1.1 North America Antibody Drugs Market Overview

5.1.2 North America 2011-2016E Antibody Drugs Local Supply, Import, Export, Local Consumption Analysis

5.1.3 North America 2011-2016E Antibody Drugs Sales Price Analysis

5.1.4 North America 2015 Antibody Drugs Market Share Analysis

5.2 Europe Antibody Drugs Market Analysis

5.2.1 Europe Antibody Drugs Market Overview

5.2.2 Europe 2011-2016E Antibody Drugs Local Supply, Import, Export, Local Consumption Analysis

5.2.3 Europe 2011-2016E Antibody Drugs Sales Price Analysis

5.2.4 Europe 2015 Antibody Drugs Market Share Analysis

5.3 Japan Antibody Drugs Market Analysis

5.3.1 Japan Antibody Drugs Market Overview

5.3.2 Japan 2011-2016E Antibody Drugs Local Supply, Import, Export, Local Consumption Analysis

5.3.3 Japan 2011-2016E Antibody Drugs Sales Price Analysis

5.3.4 Japan 2015 Antibody Drugs Market Share Analysis

5.4 China Antibody Drugs Market Analysis

5.4.1 China Antibody Drugs Market Overview

5.4.2 China 2011-2016E Antibody Drugs Local Supply, Import, Export, Local Consumption Analysis

5.4.3 China 2011-2016E Antibody Drugs Sales Price Analysis

5.4.4 China 2015 Antibody Drugs Market Share Analysis

5.5 Southeast Asia Antibody Drugs Market Analysis

5.5.1 Southeast Asia Antibody Drugs Market Overview

5.5.2 Southeast Asia 2011-2016E Antibody Drugs Local Supply, Import, Export, Local Consumption Analysis

5.5.3 Southeast Asia 2011-2016E Antibody Drugs Sales Price Analysis

5.5.4 Southeast Asia 2015 Antibody Drugs Market Share Analysis

5.6 India Antibody Drugs Market Analysis

5.6.1 India Antibody Drugs Market Overview

5.6.2 India 2011-2016E Antibody Drugs Local Supply, Import, Export, Local Consumption Analysis

5.6.3 India 2011-2016E Antibody Drugs Sales Price Analysis

5.6.4 India 2015 Antibody Drugs Market Share Analysis

6 Global 2011-2016E Antibody Drugs Segment Market Analysis (by Type)

6.1 Global 2011-2016E Antibody Drugs Sales by Type

6.2 Different Types Antibody Drugs Product Interview Price Analysis

6.3 Different Types Antibody Drugs Product Driving Factors Analysis

6.3.1 Fully human antibodies Antibody Drugs Growth Driving Factor Analysis

6.3.2 Humanized antibody Antibody Drugs Growth Driving Factor Analysis

6.3.3 Murine Antibody Drugs Growth Driving Factor Analysis

6.3.4 Chimeric antibodies Antibody Drugs Growth Driving Factor Analysis

7 Global 2011-2016E Antibody Drugs Segment Market Analysis (by Application)

7.1 Global 2011-2016E Consumption by Application

7.2 Different Application Product Interview Price Analysis

7.3 Different Application Product Driving Factors Analysis

7.3.1 Cancer Treatment Antibody Drugs Growth Driving Factor Analysis

7.3.2 Autoimmune diseases Antibody Drugs Growth Driving Factor Analysis

7.3.3 Organ Transplantation Antibody Drugs Growth Driving Factor Analysis

7.3.4 Others Antibody Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Antibody Drugs

8.1 Abbott Laboratories

8.1.1 Company Profile

8.1.2 Product Picture and Specifications

8.1.3 Abbott Laboratories 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.1.4 Abbott Laboratories 2015 Antibody Drugs Business Region Distribution Analysis

8.2 Alexion Pharmaceuticals

8.2.1 Company Profile

8.2.2 Product Picture and Specifications

8.2.3 Alexion Pharmaceuticals 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.2.4 Alexion Pharmaceuticals 2015 Antibody Drugs Business Region Distribution Analysis

8.3 Amgen

8.3.1 Company Profile

8.3.2 Product Picture and Specifications

8.3.3 Amgen 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.3.4 Amgen 2015 Antibody Drugs Business Region Distribution Analysis

8.4 Biogen Idec

8.4.1 Company Profile

8.4.2 Product Picture and Specifications

8.4.3 Biogen Idec 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.4.4 Biogen Idec 2015 Antibody Drugs Business Region Distribution Analysis

8.5 Bristol-Myers Squibb

8.5.1 Company Profile

8.5.2 Product Picture and Specifications

8.5.3 Bristol-Myers Squibb 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.5.4 Bristol-Myers Squibb 2015 Antibody Drugs Business Region Distribution Analysis

8.6 Eli Lilly And Co.

8.6.1 Company Profile

8.6.2 Product Picture and Specifications

8.6.3 Eli Lilly And Co. 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.6.4 Eli Lilly And Co. 2015 Antibody Drugs Business Region Distribution Analysis

8.7 Glaxosmithkline

8.7.1 Company Profile

8.7.2 Product Picture and Specifications

8.7.3 Glaxosmithkline 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.7.4 Glaxosmithkline 2015 Antibody Drugs Business Region Distribution Analysis

8.8 Hoffman-La Roche

8.8.1 Company Profile

8.8.2 Product Picture and Specifications

8.8.3 Hoffman-La Roche 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.8.4 Hoffman-La Roche 2015 Antibody Drugs Business Region Distribution Analysis

8.9 Johnson & Johnson

8.9.1 Company Profile

8.9.2 Product Picture and Specifications

8.9.3 Johnson & Johnson 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.9.4 Johnson & Johnson 2015 Antibody Drugs Business Region Distribution Analysis

8.10 Merck & Co.

8.10.1 Company Profile

8.10.2 Product Picture and Specifications

8.10.3 Merck & Co. 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.10.4 Merck & Co. 2015 Antibody Drugs Business Region Distribution Analysis

8.11 Dominion Biologicals Limited

8.11.1 Company Profile

8.11.2 Product Picture and Specifications

8.11.3 Dominion Biologicals Limited 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.11.4 Dominion Biologicals Limited 2015 Antibody Drugs Business Region Distribution Analysis

8.12 Novartis

8.12.1 Company Profile

8.12.2 Product Picture and Specifications

8.12.3 Novartis 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.12.4 Novartis 2015 Antibody Drugs Business Region Distribution Analysis

8.13 Seattle Genetics Inc.

8.13.1 Company Profile

8.13.2 Product Picture and Specifications

8.13.3 Seattle Genetics Inc. 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.13.4 Seattle Genetics Inc. 2015 Antibody Drugs Business Region Distribution Analysis

8.14 Spectrum Pharmaceuticals

8.14.1 Company Profile

8.14.2 Product Picture and Specifications

8.14.3 Spectrum Pharmaceuticals 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.14.4 Spectrum Pharmaceuticals 2015 Antibody Drugs Business Region Distribution Analysis

8.15 Takeda Pharmaceutical U.S.A. Inc.

8.15.1 Company Profile

8.15.2 Product Picture and Specifications

8.15.3 Takeda Pharmaceutical U.S.A. Inc. 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.15.4 Takeda Pharmaceutical U.S.A. Inc. 2015 Antibody Drugs Business Region Distribution Analysis

8.16 UCB Company

8.16.1 Company Profile

8.16.2 Product Picture and Specifications

8.16.3 UCB Company 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.16.4 UCB Company 2015 Antibody Drugs Business Region Distribution Analysis

8.17 DiaSorin S.p.A. UK Branch

8.17.1 Company Profile

8.17.2 Product Picture and Specifications

8.17.3 DiaSorin S.p.A. UK Branch 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.17.4 DiaSorin S.p.A. UK Branch 2015 Antibody Drugs Business Region Distribution Analysis

8.18 Ortho-Clinical Diagnostics.

8.18.1 Company Profile

8.18.2 Product Picture and Specifications

8.18.3 Ortho-Clinical Diagnostics. 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.18.4 Ortho-Clinical Diagnostics. 2015 Antibody Drugs Business Region Distribution Analysis

8.19 Adaltis S.r.l.

8.19.1 Company Profile

8.19.2 Product Picture and Specifications

8.19.3 Adaltis S.r.l. 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.19.4 Adaltis S.r.l. 2015 Antibody Drugs Business Region Distribution Analysis

8.20 Shanghai Rongsheng

8.20.1 Company Profile

8.20.2 Product Picture and Specifications

8.20.3 Shanghai Rongsheng 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.20.4 Shanghai Rongsheng 2015 Antibody Drugs Business Region Distribution Analysis

8.21 Wuhan Institute of Biological Products

8.21.1 Company Profile

8.21.2 Product Picture and Specifications

8.21.3 Wuhan Institute of Biological Products 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.21.4 Wuhan Institute of Biological Products 2015 Antibody Drugs Business Region Distribution Analysis

8.22 Beijing Baitai Pharma

8.22.1 Company Profile

8.22.2 Product Picture and Specifications

8.22.3 Beijing Baitai Pharma 2015 Antibody Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.22.4 Beijing Baitai Pharma 2015 Antibody Drugs Business Region Distribution Analysis

9 Development Trend of Analysis of Market

9.1 Global Market Trend Analysis

9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast

9.1.2 Global 2016-2021 Sales Price Forecast

9.1.3 Global 2016-2021 Gross Margin Forecast

9.2 Regional Market Trend

9.2.1 North America 2016-2021 Antibody Drugs Consumption Forecast

9.2.2 Europe 2016-2021 Antibody Drugs Consumption Forecast

9.2.3 Japan 2016-2021 Antibody Drugs Consumption Forecast

9.2.4 China 2016-2021 Antibody Drugs Consumption Forecast

9.2.5 Southeast Asia 2016-2021 Antibody Drugs Consumption Forecast

9.2.6 India 2016-2021 Antibody Drugs Consumption Forecast

9.3 Market Trend (Product type)

9.4 Market Trend (Application)

10 Antibody Drugs Marketing Model Analysis

10.1 Antibody Drugs Regional Marketing Model Analysis

10.2 Antibody Drugs International Trade Model Analysis

10.3 Traders or Distributors with Contact Information of Antibody Drugs by Regions

10.4 Antibody Drugs Supply Chain Analysis

11 Consumers Analysis of Antibody Drugs

11.1 Consumer 1 Analysis

11.2 Consumer 2 Analysis

11.3 Consumer 3 Analysis

11.4 Consumer 4 Analysis

…

12 New Project Investment Feasibility Analysis of Antibody Drugs

12.1 New Project SWOT Analysis of Antibody Drugs

12.2 New Project Investment Feasibility Analysis of Antibody Drugs

13 Conclusion of the Global Antibody Drugs Market Professional Survey Report 2016